Table of Contents

2019-2024 Global Intravenous Solutions (Colloids) Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Intravenous Solutions (Colloids) Consumption 2014-2024
  • 2.1.2 Intravenous Solutions (Colloids) Consumption CAGR by Region
• 2.2 Intravenous Solutions (Colloids) Segment by Type
  • 2.2.1 Peripheral Parenteral Nutrition
  • 2.2.2 Total Parenteral Nutrition
• 2.3 Intravenous Solutions (Colloids) Consumption by Type
  • 2.3.1 Global Intravenous Solutions (Colloids) Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Intravenous Solutions (Colloids) Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Intravenous Solutions (Colloids) Sale Price by Type (2014-2019)
• 2.4 Intravenous Solutions (Colloids) Segment by Application
  • 2.4.1 Hospital & Clinics
  • 2.4.2 Ambulatory
  • 2.4.3 Home Care
• 2.5 Intravenous Solutions (Colloids) Consumption by Application
  • 2.5.1 Global Intravenous Solutions (Colloids) Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Intravenous Solutions (Colloids) Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Intravenous Solutions (Colloids) Sale Price by Application (2014-2019)

3 Global Intravenous Solutions (Colloids) by Players

• 3.1 Global Intravenous Solutions (Colloids) Sales Market Share by Players
  • 3.1.1 Global Intravenous Solutions (Colloids) Sales by Players (2017-2019)
  • 3.1.2 Global Intravenous Solutions (Colloids) Sales Market Share by Players (2017-2019)
• 3.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Players
  • 3.2.1 Global Intravenous Solutions (Colloids) Revenue by Players (2017-2019)
  • 3.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Players (2017-2019)
• 3.3 Global Intravenous Solutions (Colloids) Sale Price by Players
• 3.4 Global Intravenous Solutions (Colloids) Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Intravenous Solutions (Colloids) Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Intravenous Solutions (Colloids) Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Intravenous Solutions (Colloids) by Regions

• 4.1 Intravenous Solutions (Colloids) by Regions
  • 4.1.1 Global Intravenous Solutions (Colloids) Consumption by Regions
  • 4.1.2 Global Intravenous Solutions (Colloids) Value by Regions
• 4.2 Americas Intravenous Solutions (Colloids) Consumption Growth
• 4.3 APAC Intravenous Solutions (Colloids) Consumption Growth
• 4.4 Europe Intravenous Solutions (Colloids) Consumption Growth
• 4.5 Middle East & Africa Intravenous Solutions (Colloids) Consumption Growth

5 Americas

• 5.1 Americas Intravenous Solutions (Colloids) Consumption by Countries
  • 5.1.1 Americas Intravenous Solutions (Colloids) Consumption by Countries (2014-2019)
  • 5.1.2 Americas Intravenous Solutions (Colloids) Value by Countries (2014-2019)
• 5.2 Americas Intravenous Solutions (Colloids) Consumption by Type
• 5.3 Americas Intravenous Solutions (Colloids) Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Intravenous Solutions (Colloids) Consumption by Countries
  • 6.1.1 APAC Intravenous Solutions (Colloids) Consumption by Countries (2014-2019)
  • 6.1.2 APAC Intravenous Solutions (Colloids) Value by Countries (2014-2019)
• 6.2 APAC Intravenous Solutions (Colloids) Consumption by Type
• 6.3 APAC Intravenous Solutions (Colloids) Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Intravenous Solutions (Colloids) by Countries
  • 7.1.1 Europe Intravenous Solutions (Colloids) Consumption by Countries (2014-2019)
  • 7.1.2 Europe Intravenous Solutions (Colloids) Value by Countries (2014-2019)
• 7.2 Europe Intravenous Solutions (Colloids) Consumption by Type
• 7.3 Europe Intravenous Solutions (Colloids) Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Intravenous Solutions (Colloids) by Countries
  • 8.1.1 Middle East & Africa Intravenous Solutions (Colloids) Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Intravenous Solutions (Colloids) Value by Countries (2014-2019)
• 8.2 Middle East & Africa Intravenous Solutions (Colloids) Consumption by Type
• 8.3 Middle East & Africa Intravenous Solutions (Colloids) Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Intravenous Solutions (Colloids) Distributors
• 10.3 Intravenous Solutions (Colloids) Customer

11 Global Intravenous Solutions (Colloids) Market Forecast

• 11.1 Global Intravenous Solutions (Colloids) Consumption Forecast (2019-2024)
• 11.2 Global Intravenous Solutions (Colloids) Forecast by Regions
  • 11.2.1 Global Intravenous Solutions (Colloids) Forecast by Regions (2019-2024)
  • 11.2.2 Global Intravenous Solutions (Colloids) Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Intravenous Solutions (Colloids) Forecast by Type
• 11.8 Global Intravenous Solutions (Colloids) Forecast by Application

12 Key Players Analysis

• 12.1 ICU Medical Inc.
  • 12.1.1 Company Details
  • 12.1.2 Intravenous Solutions (Colloids) Product Offered
  • 12.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 ICU Medical Inc. News
• 12.2 B. Braun Melsungen AG
  • 12.2.1 Company Details
  • 12.2.2 Intravenous Solutions (Colloids) Product Offered
  • 12.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 B. Braun Melsungen AG News
• 12.3 Fresenius Kabi AG
  • 12.3.1 Company Details
  • 12.3.2 Intravenous Solutions (Colloids) Product Offered
  • 12.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Fresenius Kabi AG News
• 12.4 Baxter
  • 12.4.1 Company Details
  • 12.4.2 Intravenous Solutions (Colloids) Product Offered
  • 12.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Baxter News
• 12.5 Amanta Healthcare
  • 12.5.1 Company Details
  • 12.5.2 Intravenous Solutions (Colloids) Product Offered
  • 12.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Amanta Healthcare News
• 12.6 Terumo Medical Corporation
  • 12.6.1 Company Details
  • 12.6.2 Intravenous Solutions (Colloids) Product Offered
  • 12.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Terumo Medical Corporation News
• 12.7 Grifols S.A.
  • 12.7.1 Company Details
  • 12.7.2 Intravenous Solutions (Colloids) Product Offered
  • 12.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Grifols S.A. News

...

13 Research Findings and Conclusion

According to this study, over the next five years the Intravenous Solutions (Colloids) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Solutions (Colloids) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions (Colloids) market by product type, application, key manufacturers and key regions and countries.

This study considers the Intravenous Solutions (Colloids) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinics
Ambulatory
Home Care

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Intravenous Solutions (Colloids) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Intravenous Solutions (Colloids) market by identifying its various subsegments.
Focuses on the key global Intravenous Solutions (Colloids) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Solutions (Colloids) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous Solutions (Colloids) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.